Startups

Scientist 3, Cell Therapy T Cell Differentiation

Genentech · South San Francisco · On-site

← All jobs
About Genentech

Genentech discovers, develops, manufactures and commercializes treatments for patients with serious and life-threatening medical conditions. Backed by North Carolina Biotechnology Center.

About the role

Bold thinkers, breakthrough makers: Join a team of curious minds who challenge the status quo, create what’s next in science and technology, and have the freedom to turn daring ideas into real breakthroughs. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • Develop, optimize, and implement robust iPSC-to-T cell differentiation protocols in the context of diverse therapeutic programs
  • Investigate cellular and molecular mechanisms underlying T-cell lineage specification, differentiation efficiency, and maturation to drive process enhancements
  • Translate biological discoveries into tangible improvements in cell-product quality, yield, phenotype, and function
  • Analyze complex, multidimensional datasets to draw incisive conclusions and guide subsequent experimental strategies
  • Collaborate cross-functionally with research, translational, computational, process development, and external partner groups across gRED
  • Contribute to scientific and strategic planning for the Cell Therapy department and Genentech’s broader therapeutic pipeline
More about this role

Bold thinkers, breakthrough makers: Join a team of curious minds who challenge the status quo, create what’s next in science and technology, and have the freedom to turn daring ideas into real breakthroughs.

The Opportunity

The Cell Therapy department within Genentech Research and Early Development (gRED) is seeking a motivated, collaborative Scientist 3 to advance next-generation, off-the-shelf cell therapies for patients with intractable diseases. Reporting to a Principal Fellow, you will play a pivotal role in shaping our iPSC-to-T cell differentiation platform, directly influencing pipeline programs and mechanistic biology discoveries.

  • Develop, optimize, and implement robust iPSC-to-T cell differentiation protocols in the context of diverse therapeutic programs.
  • Investigate cellular and molecular mechanisms underlying T-cell lineage specification, differentiation efficiency, and maturation to drive process enhancements.
  • Translate biological discoveries into tangible improvements in cell-product quality, yield, phenotype, and function.
  • Analyze complex, multidimensional datasets to draw incisive conclusions and guide subsequent experimental strategies.
  • Collaborate...

Read the full posting on Genentech's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.